VentriPoint Diagnostics (CVE:VPT) Stock Price Down 14.7% – Here’s What Happened

VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) dropped 14.7% on Tuesday . The stock traded as low as C$0.15 and last traded at C$0.15. Approximately 266,015 shares were traded during trading, a decline of 10% from the average daily volume of 294,436 shares. The stock had previously closed at C$0.17.

VentriPoint Diagnostics Stock Performance

The stock has a market cap of C$23.52 million, a PE ratio of -4.48 and a beta of 0.39. The company has a debt-to-equity ratio of -58.56, a current ratio of 0.28 and a quick ratio of 6.67. The firm has a 50 day moving average of C$0.10 and a two-hundred day moving average of C$0.13.

VentriPoint Diagnostics Company Profile

(Get Free Report)

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.

Recommended Stories

• Five stocks we like better than VentriPoint Diagnostics
• The Significance of Brokerage Rankings in Stock Selection
• NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
• Why Invest in High-Yield Dividend Stocks?
• Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
• What does consumer price index measure?
• U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave